Printer Friendly

ENDOTRONICS, INC. RECEIVES EUROPEAN PATENT ON SCALABLE OXYCELL CELL CULTURE TECHNOLOGY

 ENDOTRONICS, INC. RECEIVES EUROPEAN PATENT
 ON SCALABLE OXYCELL CELL CULTURE TECHNOLOGY
 MINNEAPOLIS, July 14 /PRNewswire/ -- Endotronics, Inc. (NASDAQ: ENDO) announced today that it received a patent from the European Patent Office for its new proprietary cell culture bioreactor, OXYCELL(TM). Endotronics previously announced that it received a U.S. patent for the technology. The patent is currently pending in Japan.
 Richard E. Sakowicz, president and chief operating officer of Endotronics, said: "We believe the OXYCELL technology will provide a key technology advantage for Endotronics. We intend to incorporate the OXYCELL technology into our next generation of systems from pilot scale to very large production scale for therapeutic bioproducts. The OXYCELL bioreactor technology is currently being used in our newest research scale instrument, the ACUMOUSE(TM). The ACUMOUSE is a cost-effective alternative to using ascites (mice) as a source of monoclonal antibodies for research into treatments for cancer, AIDS, hepatitis and other diseases."
 Endotronics, Inc., headquartered in Minneapolis, is dedicated to providing cell processing products and services to meet the emerging needs of human health care and biotechnology markets worldwide. The company is a recognized industry leader in hollow fiber cell culture instrumentation with more than 675 instruments installed worldwide.
 -0- 7/14/92
 /CONTACT: Yvonne L. Marschner-Bova of Endotronics, 313-871-7350/
 (ENDO) CO: Endotronics, Inc. ST: Minnesota IN: MTC SU:


ML -- DE006 -- 8988 07/14/92 09:48 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 14, 1992
Words:228
Previous Article:AARON RENTS ACCELERATES OPENING OF RENT-TO-OWN STORES; EXPANDS TO THREE NEW STATES
Next Article:THE SHERWIN-WILLIAMS COMPANY REPORTS SECOND QUARTER 1992 EARNINGS RESULTS
Topics:


Related Articles
ENDOTRONICS SIGNS PRODUCTION AND MARKETING AGREEMENT WITH HELIXYS
ENDOTRONICS RECEIVES JAPANESE PATENT ON CELL CULTURE TECHNOLOGY
ENDOTRONICS, INC. ANNOUNCES PURCHASE OF OPTICELL(TM) CELL CULTURE PRODUCT LINE FROM CHARLES RIVER LABORATORIES
ENDOTRONICS, INC. ANNOUNCES RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED JUNE 30, 1992
ADVANCED TISSUE SCIENCES REPORTS ALLOWANCE OF EUROPEAN PATENT
Thm Biomedical receives patent for a method and device for the reconstruction of articular cartilage.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters